Bellwether Investment Group’s Immunogen Inc IMGN Stock Holding History

Bellwether Investment Group’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-121	Closed	–	–	656
2017 Q1	$0	Hold	121	–	–	﹤0.01%	973
2016 Q4	$0	Buy	+121	New	+$243	﹤0.01%	995

Other funds holding IMGN

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bellwether Investment Group's IMGN Position: Q2 2017 in Review

Bellwether Investment Group sold out of Immunogen Inc (IMGN) in Q2 2017, closing a stake of 121 shares.

Bellwether Investment Group first reported a position in IMGN in Q4 2016 and held it in 2 quarters. The position peaked at $0 in Q1 2017. 157 funds tracked by Wall St. Rank hold IMGN as of Q2 2017.

Bellwether Investment Group reported no remaining Immunogen Inc position as of Q2 2017 after selling out during the quarter.
Bellwether Investment Group sold 121 Immunogen Inc shares in Q2 2017.
Bellwether Investment Group first reported a position in Immunogen Inc in Q4 2016 and held it in 2 quarters.
Bellwether Investment Group's Immunogen Inc position peaked at $0 in Q1 2017.
157 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2017.

Based on Bellwether Investment Group's 13F filing for Q2 2017, filed 8 Aug 2017.